# Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure

> **NCT05584241** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Michigan** · enrollment: 100 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Alzheimer Disease
- Amnestic Mild Cognitive Disorder

## Interventions

- **BEHAVIORAL:** Diagnostic Disclosure Protocol
- **BEHAVIORAL:** Biomarker Disclosure Protocol

## Key facts

- **NCT ID:** NCT05584241
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584241, "Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05584241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*